SPNT
SiriusPoint Ltd.
NYSEUSDEQUITY
Financial Services
DELAYED
Last price
23.63
▲ 0.03 (0.13%)
MARKET · —
Price
Open
23.60
Prev close
23.60
Day high
23.76
Day low
23.45
Volume
350.45K
Market cap
$2.74B
P/E (TTM)
5.82
52W range
17.17 – 26.48
Trailing performance
Returnvs SPY
1W
-0.38%
+1.0%
1M
-4.53%
-8.3%
3M
+0.42%
-2.7%
6M
+10.16%
-0.9%
YTD
+7.95%
-4.3%
1Y
+26.84%
+6.8%
3Y
+123.56%
+49.4%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Fundamentals
Market cap$2.74B
Enterprise value$2.76B
Revenue (TTM)$3.00B
Gross profit$716.10M
EBITDA$445.70M
Net income$494.70M
EPS (TTM)$4.06
Free cash flow$204.19M
Total cash$687.10M
Total debt$700.90M
Book value / share$19.61
Shares outstanding116.17M
Float101.85M
Short % of float4.48%
Dividend yield—
Beta (5Y)0.61
Valuation & profitability ratios
Trailing P/E5.82
Forward P/E8.56
PEG ratio—
Price / sales—
Price / book1.21
EV / revenue0.92
EV / EBITDA6.19
Gross margin23.86%
Operating margin13.60%
Profit margin16.85%
Return on equity23.07%
Return on assets2.18%
Debt / equity30.79
Current ratio0.66
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2019 | 2018 |
|---|---|---|---|---|
| Total revenue | $3.21B | $0 | $0 | $621.44M |
| Cost of revenue | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 |
| R&D | — | — | — | — |
| SG&A | — | — | — | — |
| Operating income | — | — | — | — |
| Pre-tax income | — | — | — | — |
| Tax provision | $0 | $0 | $0 | $0 |
| Net income | $443.60M | $183.90M | $200.62M | -$317.69M |
| EBIT | $0 | $0 | $0 | $0 |
| Line item | 2025 | 2024 | 2019 | 2018 |
|---|---|---|---|---|
| Cash & equivalents | — | — | — | — |
| Short-term investments | — | — | — | — |
| Net receivables | — | — | — | — |
| Inventory | — | — | — | — |
| Total current assets | — | — | — | — |
| Total assets | — | — | — | — |
| Total current liabilities | — | — | — | — |
| Long-term debt | — | — | — | — |
| Total liabilities | — | — | — | — |
| Retained earnings | — | — | — | — |
| Shareholder equity | — | — | — | — |
| Line item | 2025 | 2024 | 2019 | 2018 |
|---|---|---|---|---|
| Net income | $443.60M | $183.90M | $200.62M | -$317.69M |
| Depreciation | — | — | — | — |
| Change in working capital | — | — | — | — |
| Operating cash flow | — | — | — | — |
| Capital expenditure | — | — | — | — |
| Investing cash flow | — | — | — | — |
| Dividends paid | — | — | — | — |
| Buybacks | — | — | — | — |
| Financing cash flow | — | — | — | — |
| Net change in cash | — | — | — | — |
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.65 | 0.67 | +3.9% |
| Mar 2026 | 0.69 | 0.70 | +1.5% |
| Dec 2025 | 0.57 | 0.70 | +22.8% |
| Sep 2025 | 0.51 | 0.73 | +43.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.58 | 4 | $783.35M | — |
| Next quarter | 0.61 | 4 | $790.85M | -18.8% |
| Current year | 2.61 | 4 | $3.09B | -3.5% |
| Next year | 2.76 | 4 | $3.26B | +5.5% |
Analyst targets & ownership
Mean target$27.67
High target$31.00
Low target$25.00
Implied upside17.08%
Analyst count3
ConsensusNONE
Strong buy / Buy0 / 2
Hold2
Sell / Strong sell0 / 0
Held by insiders11.72%
Held by institutions87.30%
Institutions holding353
Price targets, consensus spread, insider and institutional ownership.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
13.62M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| May 29, 26 | MAHMUD MEHDI Director |
STOCK | 5.90K | $137.48K | Direct |
| May 29, 26 | LUDLOW SHARON M Director |
STOCK | 5.90K | $137.48K | Direct |
| May 29, 26 | PURTILL SABRA R Director |
STOCK | 5.90K | $137.48K | Direct |
| May 29, 26 | ROBART JASON Director |
STOCK | 5.90K | $137.48K | Direct |
| May 29, 26 | MASOJADA BRONISLAW EDMUND Director |
STOCK | 5.90K | $137.48K | Direct |
| May 29, 26 | HUDSON MARTIN PETER Director |
STOCK | 5.90K | $137.48K | Direct |
| May 29, 26 | CROSS SUSAN LEE Director |
STOCK | 5.90K | $137.48K | Direct |
| Apr 28, 26 | MCKINNEY JAMES J Chief Financial Officer |
STOCK | 15.18K | $0 | Direct |
| Apr 28, 26 | GOVRIN DAVID E Officer |
STOCK | 19.93K | $0 | Direct |
| Apr 28, 26 | EGAN SCOTT Chief Executive Officer |
STOCK | 48.63K | $0 | Direct |
| Apr 28, 26 | GIBBS ROBIN Officer |
STOCK | 10.77K | $0 | Direct |
| Apr 28, 26 | SHAPELLA ANTHONY Officer |
STOCK | 5.89K | $0 | Direct |
| Apr 28, 26 | CHARLES PATRICK JOHN Officer |
STOCK | 10.72K | $0 | Direct |
| Apr 28, 26 | LEONARDO THOMAS C. Officer |
STOCK | 12.75K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
CHARLES PATRICK JOHN |
Officer | 146.73K | Stock Award(Grant) |
DE LA GUERONNIERE RAPHAEL |
Director | 127.58K | Sale |
EGAN SCOTT |
Chief Executive Officer | 1.46M | Stock Award(Grant) |
GIBBS ROBIN |
Officer | 166.24K | Stock Award(Grant) |
GOVRIN DAVID E |
Officer | 677.70K | Stock Award(Grant) |
LEONARDO THOMAS C. |
Officer | 253.11K | Stock Award(Grant) |
LOEB DANIEL S |
Director | — | Sale |
LUDLOW SHARON M |
Director | 160.69K | Stock Award(Grant) |
MAHMUD MEHDI |
Director | 123.56K | Stock Award(Grant) |
MONTROSS FRANKLIN IV |
Director | 103.28K | Stock Award(Grant) |
Moving averages & technicals
SMA 10
23.27
+1.55% from price
SMA 20
23.78
-0.63% from price
SMA 50
23.97
-1.40% from price
SMA 100
23.36
+1.15% from price
SMA 200
22.08
+7.03% from price
EMA 12
23.53
+0.44% from price
EMA 26
23.72
-0.38% from price
EMA 50
23.68
-0.20% from price
RSI (14)
48.8
Neutral
MACD (12,26,9)
-0.19
Hist 0.01
ATR (14)
0.56
2.37% of price
Realised vol 30D
33.9%
Annualised
Bollinger upper
25.72
20, 2σ
Bollinger lower
21.84
20, 2σ
50 / 200 cross
Golden
23.97 vs 22.08
Trend bias
Above 200
+7.03%
Risk profile
Beta vs SPY
0.06
Less volatile than market
Correlation to SPY
0.03
Largely independent
Realised vol 30D
33.9%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-14.7%
Peak to trough
Max drawdown 5Y
-58.7%
Peak to trough
ATR 14
0.56
2.37% of price
Beta (reported)
0.61
5Y monthly, from filing
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Options analytics
Put / call volume
0.02
Call-heavy session
Put / call open interest
0.02
Positioning, not flow
Max pain
12.50
-47.1% from spot
ATM implied vol
83.6%
Nearest strike to spot
Skew (10% OTM)
+10.4%
Puts bid over calls
Call volume
51
Contracts, this expiry
Put volume
1
Contracts, this expiry
Heaviest call OI
30.00
73 contracts
Heaviest put OI
20.00
2 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Headlines
Should Value Investors Buy Assurant (AIZ) Stock?
Zacks · 2d ago
SiriusPoint (SPNT) Could Be 11% Undervalued As Earnings Refocus Attention
Simply Wall St. · 18d ago
SiriusPoint (SPNT) Is Down 9.0% After Earnings Beat And Valuation Buzz - Has The Bull Case Changed?
Simply Wall St. · 18d ago
Is SiriusPoint (SPNT) Stock Still Trading At A Discount After A 140% Five Year Return?
Simply Wall St. · 18d ago
Should Value Investors Buy SiriusPoint (SPNT) Stock?
Zacks · 19d ago
SiriusPoint Q2 Earnings Call Highlights
MarketBeat · 22d ago
SiriusPoint Ltd (SPNT) (Q2 2026) Earnings Call Highlights: Strong Underwriting Profitability ...
GuruFocus.com · 23d ago
SiriusPoint Q2 Non-GAAP Earnings Rise, Revenue Declines
MT Newswires · 24d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.